User profiles for Oriol Dols

Oriol Dols-Icardo

Sant Pau Biomedical Research Institute
Verified email at santpau.cat
Cited by 4536

Dementia risk in Parkinson disease: disentangling the role of MAPT haplotypes

…, M Suárez-Calvet, L Molina-Porcel, O Dols… - Archives of …, 2011 - jamanetwork.com
Background Dementia in Parkinson disease (PD) causes nursing home placement, caregiver
distress, higher health care burden, and increased mortality. Objective To determine …

The SORL1 p. Y1816C variant causes impaired endosomal dimerization and autosomal dominant Alzheimer's disease

…, L Bossaerts, C Van Broeckhoven, O Dols… - MedRxiv, 2023 - medrxiv.org
Truncating genetic variants of SORL1, encoding the endosome recycling receptor SORLA,
have been accepted as causal of Alzheimer's disease (AD). However, most genetic variants …

Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies

…, F Danjou, M Diez-Fairen, O Dols-Icardo… - The Lancet …, 2019 - thelancet.com
Background Genome-wide association studies (GWAS) in Parkinson's disease have increased
the scope of biological knowledge about the disease over the past decade. We aimed to …

Dissecting phenotypic traits linked to human resilience to Alzheimer's pathology

BG Perez-Nievas, TD Stein, HC Tai, O Dols-Icardo… - Brain, 2013 - academic.oup.com
Clinico-pathological correlation studies and positron emission tomography amyloid imaging
studies have shown that some individuals can tolerate substantial amounts of Alzheimer’s …

Identification of candidate Parkinson disease genes by integrating genome-wide association study, expression, and epigenetic data sets

…, Y Compta, M Diez-Fairen, O Dols-Icardo… - JAMA …, 2021 - jamanetwork.com
Importance Substantial genome-wide association study (GWAS) work in Parkinson disease (PD)
has led to the discovery of an increasing number of loci shown reliably to be associated …

Glucocerebrosidase mutations confer a greater risk of dementia during Parkinson's disease course

…, B Pascual‐Sedano, O Dols‐Icardo… - Movement …, 2012 - Wiley Online Library
Mutations in the glucocerebrosidase gene are associated with Parkinson's disease and Lewy
body dementia. However, whether these alterations have any effect on the clinical course …

[HTML][HTML] Clinicopathological correlates in frontotemporal lobar degeneration: motor neuron disease spectrum

…, R Sánchez-Valle, I Illán-Gala, O Dols-Icardo… - Brain, 2024 - academic.oup.com
Amyotrophic lateral sclerosis (ALS) is a devastating motor neuron disease (MND) that shares
a common clinical, genetic and pathologic spectrum with frontotemporal dementia (FTD). It …

Characterization of the repeat expansion size in C9orf72 in amyotrophic lateral sclerosis and frontotemporal dementia

O Dols-Icardo, A García-Redondo… - Human molecular …, 2014 - academic.oup.com
Hexanucleotide repeat expansions within the C9orf72 gene are the most important genetic
cause of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). The …

[HTML][HTML] Genome-wide meta-analysis for Alzheimer's disease cerebrospinal fluid biomarkers

…, J Diehl-Schmid, S Djurovic, O Dols-Icardo… - Acta …, 2022 - Springer
Amyloid-beta 42 (Aβ42) and phosphorylated tau (pTau) levels in cerebrospinal fluid (CSF)
reflect core features of the pathogenesis of Alzheimer’s disease (AD) more directly than …

Assessing the role of the TREM2 p. R47H variant as a risk factor for Alzheimer's disease and frontotemporal dementia

A Ruiz, O Dols-Icardo, MJ Bullido, P Pastor… - Neurobiology of …, 2014 - Elsevier
… Author links open overlay panel Agustín Ruiz a , Oriol Dols-Icardo b c , María J. Bullido c d
e , Pau Pastor c f g , Eloy Rodríguez-Rodríguez c h , Adolfo López de Munain c i , Marian M. …